Testing New Ways to Enroll At-Risk Populations in Clinical Research

A new award from the HIV Vaccine Trials Network will allow investigators to evaluate whether the computer tablet-based health survey “e-screening” tool, Promote Health, will help recruit and retain high-risk individuals into an HIV prevention clinical trial. 

New Opportunity for Postdoctoral Research in Population Health

The UR CTSI is implementing a new Population Health Research Postdoctoral Fellowship Program to produce population health researchers who can conceptualize research across the translational spectrum – from molecules to populations. Positions are open to scientists with backgrounds in basic, clinical, translational, or population health research.

BUILDing Diversity in Clinical Trials through Collaborations

Researchers from URMC and Xavier University have developed a collaboration through the BUilding Infrastructure Leading to Diversity (BUILD) network to improve diversity in cancer clinical trials. The group aims to raise researchers’ cultural competency and educate underrepresented populations about the importance of participating in clinical trials.

The Legacy of Tuskegee

Forty-six years have passed since the whistle was blown on the Tuskegee syphilis experiment for its unethical treatment of poor Black men in Alabama, but a research suggests its the study has had long-lasting effects on the health of Black and African American men. 

Former KL2 Scholar Honored as Brilliant New Investigator

Past KL2 scholar, Feng (Vankee) Lin, PhD, RN, is set to receive the Brilliant New Investigator Award from the Council for the Advancement of Nursing Science (CANS) this fall. Lin is an early stage investigator in the UR School of Nursing who has demonstrated extraordinary potential to have a significant impact on the science and practice of nursing and health care.